Showing results (1701-1710 of 2,293) with videos related to
Sort By:
Pageof 230
Scientific Reports|February 29, 2020
Disrupted principal network organisation in multiple sclerosis relates to disabilityThalis Charalambous, Jonathan D Clayden, Elizabeth Powell, et al.Neuroimage. Clinical|January 8, 2021
FLAIR-only joint volumetric analysis of brain lesions and atrophy in clinically isolated syndrome (CIS) suggestive of multiple sclerosisO Goodkin, F Prados, S B Vos, et al.Elife|December 3, 2019
Coronary arterial development is regulated by a Dll4-Jag1-EphrinB2 signaling cascadeStanislao Igor Travisano, Vera Lucia Oliveira, Belén Prados, et al.Journal of Bacteriology|January 20, 2021
The Phosphatidyl-myo-Inositol Dimannoside Acyltransferase PatA Is Essential for Mycobacterium tuberculosis Growth In Vitro and In VivoFrancesca Boldrin, Itxaso Anso, Sogol Alebouyeh, et al.The Journal of Biological Chemistry|May 24, 2019
The structural unit of melanin in the cell wall of the fungal pathogen Cryptococcus neoformansEmma Camacho, Raghav Vij, Christine Chrissian, et al.ACS Chemical Biology|October 3, 2012
Insights into the glycosaminoglycan-mediated cytotoxic mechanism of eosinophil cationic protein revealed by NMRM Flor García-Mayoral, Angeles Canales, Dolores Díaz, et al.Case Reports in Oncology|August 15, 2024
Long-Term Survival in Hepatocellular Carcinoma following Second-Line Tumor Treating Fields Therapy and Sorafenib: A Case ReportMarisa Torres Velasco, Rafael Álvarez Gallego, Paloma Peinado, et al.Brain Communications|May 28, 2026
Disability profiles in progressive multiple sclerosis reflect pathology distribution, independent of clinical phenotypeErmelinda De Meo, Amy E Jolly, Marco Ganzetti, et al.Neuro-Oncology|April 17, 2001
A phase I trial of 1,3-bis(2-chloroethyl)-1-nitrosourea plus temozolomide: a North American Brain Tumor Consortium studyS C Schold, J G Kuhn, S M Chang, et al.Neuro-Oncology|April 4, 2003
A randomized, double-blind, placebo-controlled, phase 2 study of RMP-7 in combination with carboplatin administered intravenously for the treatment of recurrent malignant gliomaMichael D Prados, S Clifford Schold, Howard A Fine, et al.Pageof 230